Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis (HLH)
The diagnosis of HLH requires either a molecular diagnosis consistent with HLH or fulfillment of 5 out of 8 specific diagnostic criteria according to the HLH-2004 guidelines. 1, 2
HLH-2004 Diagnostic Criteria
HLH can be diagnosed if either of the following is fulfilled:
Molecular diagnosis consistent with HLH 1, 2
- Genetic testing showing mutations in HLH-associated genes
OR 5 of the 8 following criteria 1, 2:
- Fever 1
- Splenomegaly 1
- Cytopenias affecting ≥2 of 3 lineages in peripheral blood:
- Hemoglobin <90 g/L (<100 g/L in infants <4 weeks)
- Platelets <100 × 10^9/L
- Neutrophils <1.0 × 10^9/L 1
- Hypertriglyceridemia and/or hypofibrinogenemia:
- Fasting triglycerides ≥3.0 mmol/L (≥265 mg/dL)
- Fibrinogen ≤1.5 g/L 1
- Hemophagocytosis in bone marrow, spleen, or lymph nodes without evidence of malignancy 1
- Low or absent NK cell activity (according to local laboratory reference) 1
- Ferritin ≥500 μg/L 1
- Soluble IL-2 receptor (sCD25) ≥2400 U/mL 1
Important Clinical Considerations
Hyperferritinemia is a key marker for HLH diagnosis:
Soluble IL-2 receptor (sCD25) is an excellent diagnostic test for adult HLH with an area under the curve of 0.90 compared to 0.78 for ferritin 1
Despite the name, hemophagocytosis is neither sensitive nor specific for HLH and may not be present initially 1
- If not found on initial examination, further searches in other organs or serial bone marrow aspirates are recommended 1
Alternative Diagnostic Tool: HScore
- The HScore is an alternative scoring system developed specifically for adults with suspected secondary HLH 2
- Parameters included in the HScore:
- Known underlying immunosuppression (0 or 18 points)
- Temperature (0,33, or 49 points based on range)
- Organomegaly (0,23, or 38 points)
- Number of cytopenias (0,24, or 34 points)
- Ferritin level (0,35, or 50 points)
- Triglyceride level (0,44, or 64 points)
- Fibrinogen level (0 or 30 points)
- AST level (0 or 19 points)
- Hemophagocytosis on bone marrow aspirate (0 or 35 points) 1
- An HScore cutoff of 169 has shown mean sensitivity of 82.4% and specificity of 87.6% across multiple cohorts 4
Supportive Diagnostic Findings
Additional findings that support the diagnosis of HLH include:
- Spinal fluid pleocytosis and/or elevated spinal fluid protein 1
- Liver histology resembling chronic persistent hepatitis 1
- Cerebromeningeal symptoms, lymph node enlargement, jaundice, edema, skin rash 1
- Hepatic enzyme abnormalities, hypoproteinemia, hyponatremia 1
- Elevated VLDL and low HDL 1
Diagnostic Pitfalls and Caveats
- The HLH-2004 criteria were developed for children and are not formally validated in adults, though they remain the standard diagnostic approach 1, 6
- Treatment should not be delayed if HLH is strongly suspected, even if all 5 criteria are not yet fulfilled 1
- In resource-limited settings where NK cell activity and sCD25 testing are unavailable, modified criteria with a cutoff of 4 out of 6 available criteria may be used 5
- A comprehensive search for underlying triggers (infections, malignancies, autoimmune disorders) should be conducted even during ongoing HLH treatment 1
- Ferritin >6,000 μg/L has been identified as an independent prognostic factor for inferior survival 5